- Else Nutrition (BABY) has more than tripled its production capacity in line with increasing demand
- The company reached the milestone by adding a second U.S. powder production facility, while initial commercial European production is slated for later this month
- It will perform three production campaigns this month to resolve out-of-stock issues
- Hamutal Yitzhak, Else’s CEO and Co-Founder, sat down with Sabrina Phillips to discuss the news
- Else Nutrition is developing clean, plant-based food and nutrition products for infants, toddlers, children and adults
- Else Nutrition (BABY) opened with a gain of 2.94 per cent, trading at $0.70 per share
Else Nutrition (BABY) has more than tripled its production capacity in line with increasing demand.
The company reached the milestone by adding a second U.S. powder production facility, while initial commercial European production is slated for later this month.
The additions are in response to fast-growing demand from brick-and-mortar retailers, Amazon and Else’s e-commerce store.
Else will perform three production campaigns this month, two in the U.S. and one in Europe, to resolve out-of-stock issues.
Hamutal Yitzhak, Else’s CEO and Co-Founder, sat down with Sabrina Phillips to discuss the news.
“The additional production facilities will allow us to stabilize our production and build up sufficient inventory levels to meet the robust demand from our customers. We are excited to have entered a new phase in our journey, where leading grocery and mass North American retailers are now adding our products to their shelves. Our ability to properly support this fast-growing demand is critical for our success.”
Else Nutrition is developing clean, plant-based food and nutrition products for infants, toddlers, children and adults.
Else Nutrition (BABY) opened with a gain of 2.94 per cent, trading at $0.70 per share.
